ABT vs ON · P/E 25, rev $44.33B vs P/E 36, rev $3.12B
Abbott Laboratories (ABT) versus ON Semiconductor Corporation (ON) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
ON Semiconductor Corporation (ON) is a semiconductors company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ON revenue for 2026-07-03 was $3.12B. Net income was $193.4M. ON currently screens at market cap $21.90B and trailing P/E 36.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ON currently screens at market cap $21.90B and trailing P/E 36.4.
Not investment advice. Open the ABT and ON stock pages for the full models.
Not investment advice.